Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,826 | 6,158 | 3,891 | 5,787 | 7,381 |
| TOTAL | $6,439 | $6,413 | $4,961 | $6,618 | $7,629 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 401 | 426 | 451 | 720 | 610 |
| TOTAL | $401 | $426 | $451 | $720 | $610 |
| Total Assets | $6,840 | $6,839 | $5,412 | $7,339 | $8,240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,226 | 1,976 | 2,552 | 3,310 | 2,129 |
| TOTAL | $2,234 | $8,513 | $2,612 | $3,394 | $2,233 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 4 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $4 |
| Total Liabilities | $2,234 | $8,513 | $2,612 | $3,394 | $2,237 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,751 | 1,107 | 572 | 515 | 364 |
| Common Shares | 16 | 6 | 160 | 4 | 102 |
| Retained earnings | -73,176 | -70,201 | -64,972 | -60,439 | -56,308 |
| TOTAL | $4,606 | $-1,673 | $2,800 | $3,945 | $6,003 |
| Total Liabilities And Equity | $6,840 | $6,839 | $5,412 | $7,339 | $8,240 |